Related Experiment Videos

Adjuvant therapy for all patients with breast cancer?

M E Lippman, D F Hayes

Journal of the National Cancer Institute

|February 24, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.

Breast cancer research and treatment·2019

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).

Annals of oncology : official journal of the European Society for Medical Oncology·2018

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Breast cancer research and treatment·2017

See all related articles